Back

Real-world assessment of antiplatelet treatment therapies for acute coronary syndrome (ACS) patients in the United States in a nationwide Electronic Health Record in 2018-2020

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Real-world evidence in acute coronary syndromes (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Ms Amiee Kang

Bristol Myers Squibb, Princeton (United States of America)

6 More presentations in this session

Presentation thumbnail
Immediate, early and late ventricular fibrillation complicating acute myocardial infarction: insights from a real life registry
Doctor O. Weizman (Paris, FR)
Abstract Slides Video
Presentation thumbnail
In-hospital prognosis of recreational drug use in patients with acute ST-elevation myocardial infarction: insights from the ADDICT-ICCU study
Doctor A. Clement (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Improving myocardial infarction emergency care: a joint intervention study of the Berlin Brandenburg Myocardial Infarction Registry (B2HIR) and emergency medical services (QS-Notfall)
Assistant Professor M. Stockburger (Nauen, DE)
Abstract Slides Video
Presentation thumbnail
Performance of the High-STEACS Early Rule-Out Pathway for High Sensitivity Cardiac Troponin T at 30-days in a US population
Doctor B. Allen (Gainesville, US)
Abstract Slides Video
Presentation thumbnail
Adherence to guideline-directed medical therapy and 3-year clinical outcome following acute myocardial infarction
Ms D. Hyun (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Real-world evidence in acute coronary syndromes (1)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis
thumbnail
Congress Presentation
Real-world implementation of a genotype-guided p2y12-inhibitor de-escalation strategy in acute coronary syndrome patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources